Dennis Aguiling

Dennis Aguiling currently serves as Associate Director at Respira Therapeutics, Inc. since October 2023. Previously held the position of Director of Clinical Operations at Curevo Vaccine and Spruce Biosciences. Experience includes key roles at Nektar Therapeutics as Sr. Clinical Trial Manager and at Immune Design as Clinical Trial Manager. Dennis started a career in clinical research at Gilead Sciences, rising from Clinical Project Assistant to Senior Clinical Trial Management Associate. Earlier professional experience spans clinical research coordination at UCSF and consulting roles in fashion. Dennis earned a Bachelor of Arts in Psychology from the University of San Francisco.